Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
Doxorubicin is used and highly effective chemotherapeutic agent; however, its clinical utility remains limited by dose‐dependent cardiotoxicity, presenting a significant challenge in cancer management. Growing preclinical research and clinical evidence suggest that the antioxidant vitamin C (ascorbi...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2025-08-01
|
| シリーズ: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| 主題: | |
| オンライン・アクセス: | https://www.ahajournals.org/doi/10.1161/JAHA.125.042534 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
